INS and Hypoglycemia: At the study visit, 213 patients [21.8% (95% CI: 19.2–24.4%)] in the insulin glargine group and 241 [47.6% (95% CI: 43.3–52.2%)] in the NPH insulin groups had experienced hypoglycaemia (any category) in the previous month (p < 0.0001).